Skip to main content
. 2023 May 20;9(3):295–307. doi: 10.1007/s41030-023-00226-y

Fig. 1.

Fig. 1

Process of post-COVID pulmonary fibrosis and risk factors. ACE-2 angiotensin-converting enzyme, DAMP damage-associated molecular patterns, ANG II angiotensin II, EGF epidermal growth factor, PDGF platelet derived growth factor, TGF-β tumor growth factor β